Evidence map›Paper›PMID 41561667›Full record

ArticleAmerican journal of ophthalmology case reports2026

Annamaria Nunziata, Lorenzo Bianco, Alessio Antropoli, Alessandro Arrigo, Francesco Bandello, Ahmad M Mansour, Maurizio Battaglia Parodi

Abstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Annamaria NunziataSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Lorenzo BiancoSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Alessio AntropoliSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Alessandro ArrigoSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Francesco BandelloSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Ahmad M MansourDepartment of Opthalmology, American University of Beirut, Beirut, Lebanon.
Maurizio Battaglia ParodiSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To describe a rare case of severe central and peripheral chorioretinal atrophy in a patient with Observations: A 66-year-old man with a 20-year history of Stargardt disease and HIV/AIDS treated with didanosine for almost ten years in the late '90s presented with progressive bilateral visual loss and color desaturation. Best-corrected visual acuity was 20/400 in both eyes. Multimodal imaging revealed extensive retinal pigment epithelium and choroidal atrophy involving both the macula and mid-periphery, with macular thinning and structural damage confirmed on optical coherence tomography. The peripheral atrophy pattern was consistent with known didanosine toxicity, while the macular degeneration was typical of Conclusions and importance: This case suggests that prior mitochondrial-toxic drug exposure may exacerbate the course of inherited retinal dystrophies, producing unusually severe panretinal degeneration. Clinicians should review medication history in patients with inherited retinal diseases and consider long-term retinal monitoring even years after discontinuing potentially toxic agents.

Indexed as

ABCA4-Associated retinopathyChorioretinal atrophyDidanosine toxicityInherited retinal dystrophyStargardt disease

Identifiers

PMID41561667
PMCPMC12813201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.